Madrigal Pharmaceuticals, Inc. - Rasio total nilai perusahaan marang pendapatan MDGL

madrigalpharma.com (MDGL) - logo korporat

Madrigal Pharmaceuticals (MDGL) delegates drug manufacturing to external contractors, securing these partnerships through strict agreements. The EV/Sales trajectory reflects the market valuation of the business excluding debt, with 6028.64 determining the current value of this metric. Madrigal Pharmaceuticals (MDGL) implements bold scientific solutions for the therapy of severe liver pathologies. The monopoly launch of Rezdiffra following years of research will provide the firm with powerful operating leverage and access to a massive market.

MDGL Madrigal Pharmaceuticals: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Madrigal Pharmaceuticals Inc - rincian analitis lan metrik utama (MDGL)

Pambiji fundamental perusahaan:madrigalpharma.com, MDGL
Produk asil prodhuksi Madrigal Pharmaceuticals, Inc.

For the biopharmaceutical business of Madrigal Pharmaceuticals (MDGL), the EV/Sales valuation serves as a tool for analyzing the enterprise value relative to generated revenue, excluding debt load. This metric correlates the total value of assets and liabilities with sales volume, allowing the influence of capital structure to be removed from the fundamental valuation. The trend in this EV/Sales valuation reveals abnormal price reactions to clinical trial results or changes in drug insurance coverage.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|CORT: Multiplikator EV/Sales|RYTM - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Akero Corp|Metsera Therapeutics (MTSR) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan moonlaketx.com (MLTX)|Nilai perusahaan marang pendapatan Crinetics Pharmaceuticals CRNX|Rasio nilai perusahaan marang pendapatan NewAmsterdam Pharma N.V. NAMS|Rasio total nilai perusahaan marang pendapatan Soleno Therapeutics Inc (SLNO)|FOLD - Rasio nilai perusahaan marang pendapatan|ETNB: Rasio nilai perusahaan marang pendapatan|AGIO: Multiplikator EV/Sales|Structure Therapeutics Inc. - Nilai bisnis marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)